10-48450411-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_021226.4(ARHGAP22):c.1718C>A(p.Ala573Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000382 in 1,570,388 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_021226.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ARHGAP22 | NM_021226.4 | c.1718C>A | p.Ala573Glu | missense_variant | 9/10 | ENST00000249601.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ARHGAP22 | ENST00000249601.9 | c.1718C>A | p.Ala573Glu | missense_variant | 9/10 | 1 | NM_021226.4 | P4 |
Frequencies
GnomAD3 genomes AF: 0.0000328 AC: 5AN: 152210Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000391 AC: 7AN: 178830Hom.: 0 AF XY: 0.0000724 AC XY: 7AN XY: 96656
GnomAD4 exome AF: 0.0000395 AC: 56AN: 1418060Hom.: 1 Cov.: 36 AF XY: 0.0000442 AC XY: 31AN XY: 701552
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152328Hom.: 0 Cov.: 34 AF XY: 0.0000268 AC XY: 2AN XY: 74502
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 03, 2022 | The c.1718C>A (p.A573E) alteration is located in exon 9 (coding exon 9) of the ARHGAP22 gene. This alteration results from a C to A substitution at nucleotide position 1718, causing the alanine (A) at amino acid position 573 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at